Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New imidazole derivatives as aromatase inhibitor: Design, synthesis, biological activity, molecular docking, and computational ADME-Tox studies
Gökay Çetiner, Ulviye Acar Çevik, İsmail Çeli̇k, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134920-134920
Closed Access | Times Cited: 11

Showing 11 citing articles:

Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs
Sara Janowska, Serhii Holota, Roman Lesyk, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 346-346
Open Access | Times Cited: 7
Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023)
Neha Bhatia, Suresh Thareja
Bioorganic Chemistry (2024) Vol. 151, pp. 107607-107607
Closed Access | Times Cited: 7
Computational Discovery of Novel Imidazole Derivatives as Inhibitors of SARS-CoV-2 Main Protease: An Integrated Approach Combining Molecular Dynamics and Binding Affinity Analysis
Benjamin Ayodipupo Babalola, Abayomi Emmanuel Adegboyega
COVID (2024) Vol. 4, Iss. 6, pp. 672-695
Open Access | Times Cited: 6
New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAF V600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study
Wael A.A. Fadaly, Mohamed T. M. Nemr, Taha H. Zidan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 13
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents
Ulviye Acar Çevik, İsmail Çeli̇k, Leyla Paşayeva, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 5
Closed Access | Times Cited: 10
Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors
Sena Demiraran, Derya Osmani̇ye, Yusuf Özkay, et al.
Journal of Molecular Structure (2023) Vol. 1296, pp. 136903-136903
Closed Access | Times Cited: 10
Synthesis of Novel Benzenesulfonamide-Bearing Functionalized Imidazole Derivatives as Novel Candidates Targeting Multidrug-Resistant Mycobacterium abscessus Complex
Benas Balandis, Povilas Kavaliauskas, Birutė Grybaitė, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 935-935
Open Access | Times Cited: 3
Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure–Activity Relationship Studies
Kapil Kumar Goel, Somesh Thapliyal, Rajeev Kharb, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2208-2208
Open Access | Times Cited: 3
Synthesis、characterization and antifungal activity of imidazole chitosan derivatives
Lulu Wu, Liangxin Fan, Lijun Shi, et al.
Carbohydrate Research (2024) Vol. 544, pp. 109238-109238
Closed Access
Computational Discovery of Potent Imidazole Derivatives as Inhibitors of SARS-CoV-2 Main Protease: An Integrated Approach Combining Molecular Dynamics and Binding Affinity Analysis
Benjamin Ayodipupo Babalola, Abayomi Emmanuel Adegboyega
Research Square (Research Square) (2023)
Open Access
Unlocking the potential of aromatase inhibitors: recent advances in drug design, synthesis, docking activity, and in vitro bioactivity evaluations
Niloufar Moharrer Navaei, Narvan Moharrer Navaei
Synthesis and Sintering (2023) Vol. 3, Iss. 4
Open Access
Page 1

Scroll to top